HomeAdvocacy Advocacy News

Advocacy News

Displaying results 1-10 (of 159)
 |<  < 1 2 3 4 5 6 7 8 9 10  >  >| 

CSRO Presents on PBMs at the Board of Hispanic Caucus Chairs Conference

CSRO Vice President, Dr. Madelaine Feldman recently presented on Pharmacy Benefit Managers and utilization management tools at the Board of Hispanic Caucus Chairs meeting in Las Vegas, Nevada.

READ MORE

FSR President Testifies on PBMs and the Rebate System

Dr. Robert Levin, President of the Florida Society of Rheumatology recently testified to the House Health Innovation Subcommittee on the role that Pharmacy Benefit Managers have played in inflating the cost of prescription drugs.

READ MORE

CSRO & FSR Discuss Utilization Management in Tallahassee

On Tuesday, December 5th, CSRO hosted a reception for Florida legislators in partnership with the Florida Society of Rheumatology (FSR). An array of stakeholders including patients and physicians met and spoke with legislators that are deeply invested in CSRO and FSR’s shared priorities.

READ MORE

FDA Biosimilars Educational Material

To date, the U.S. Food and Drug Administration (FDA) has approved seven biosimilars, and some are already on the market. As the biosimilars market continues to grow, there are still a lot of questions from both patients and physicians about these important new treatment options.

READ MORE

CSRO Opposes Efforts to Establish a National Benchmark Plan Standard for Prescription Drugs

The CSRO has submitted comments to CMS expressing concerns with their intent to establish a national benchmark plan standard for prescription drugs in future years.

READ MORE

CSRO Responds to Federal Innovation Center RFI

The CSRO has responded to a request for information (RFI) from the Innovation Center as the federal agency plans for a new direction. The comments submitted focus on specific issues that uniquely impact practicing rheumatologists and the patients they serve.

READ MORE

CSRO Presents at the Patient and Health Advocacy Bio Summit

Dr. Madelaine Feldman traveled to Washington D.C. recently to attend the Patient and Health Advocacy Bio Summit.

READ MORE

CSRO and Allies Submit Comments to Anthem on Utilization Management Changes for Osteoarthritis Patients

As patient and physician advocates, the Coalition of State Rheumatology Organizations (CSRO) actively monitors changes that affect physician’s ability to effectively treat their patients and operate their practices.

READ MORE

CSRO Delivers Testimony on Utah Step Therapy

On September 20, 2017, Dr. Joshua Stolow traveled to Utah to testify on the necessity of patient protection legislation addressing step therapy protocols.

READ MORE

CSRO Submits Comments to CMS on Proposed Revisions for 2018

As patient and physician advocates, the CSRO actively monitors regulatory changes that affect physician’s ability to effectively treat their patients and operate their practices. As such, the CSRO took note of and discussed revisions proposed by the Center for Medicare and Medicaid Services for 2018.

READ MORE

Displaying results 1-10 (of 159)
 |<  < 1 2 3 4 5 6 7 8 9 10  >  >|